Kymera Therapeutics (NASDAQ:KYMR) Coverage Initiated by Analysts at BMO Capital Markets
Research analysts at BMO Capital Markets began coverage on shares of Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) in a research report issued on Friday,Briefing.com Automated Import reports. The brokerage set a “market perform” rating and a $55.00 price target on the stock. BMO Capital Markets’ price objective points to a potential upside of 24.77% […]
More Stories
How AI Can Help Businesses Reduce Website Development Costs
In 2023, McKinsey set up a lab and timed more than 40 of its own software developers on routine tasks,...
iPhone Overheating? Common Causes and Fixes
Apple designs its phones to work in different environments, including high air pressure, humidity, and hot and cold weather. When...
Global Trade’s New Geography: Developing Economies Face a Choice
By Looking Times | 14 November 2026 Photo: Igor Ovsyannykov, “Shipping containers in a port” (Port of Barcelona), via Wikimedia...
The AI Investment Boom: Can Record Spending Deliver Real Productivity?
Global Trade in 2026: AI Investment Is Rewriting the Map of World Commerce By Looking Times | November 13, 2026...
The AI Investment Boom: Can Record Spending Deliver Real Productivity?
The AI Investment Boom: Can Record Spending Deliver Real Productivity? By Looking Times | November 13, 2026 Image: Derrick Coetzee,...
Global Trade in 2026: How AI Is Reshaping the World Economy
Global shipping remains a vital link in international trade. Image: Wilfredor, Wikimedia Commons, CC0 1.0 (public domain dedication). Image source...